Suchergebnisse - "Gibson, Peter R"

PubPharm (16)

1

Application of a Precision-Dosing Model to a Real-World Cohort of Patients on Infliximab Maintenance Therapy : Drug Usage and Cost Analysis

enthalten in: Journal of clinical pharmacology | 2024

von Nguyen, A. | Gibson, P. | Upton, R. | +2

2

Pharmacist-Driven Therapeutic Infliximab Monitoring at the Point of Care Using Rapidly Assessed Drug Levels in Patients with Inflammatory Bowel Disease

enthalten in: Therapeutic drug monitoring | 2023

von Rentsch, C. | Ward, M. | Luber, R. | +9

3

Timing of Live Attenuated Vaccination in Infants Exposed to Infliximab or Adalimumab in Utero : A Prospective Cohort Study in 107 Children

enthalten in: Journal of Crohn's & colitis | 2022

von Liu, Z. | Julsgaard, M. | Zhu, X. | +30

4

Anti-TNFα Induction Therapy for Patients With Active Inflammatory Bowel Disease During Pregnancy : A Case Series

enthalten in: Inflammatory bowel diseases | 2022

von MacIsaac, M. | Julsgaard, M. | Flanagan, E. | +5

5

Comparison of SB2-Infliximab With Originator-Infliximab in the Measurement of Serum Concentrations : A Short Communication

enthalten in: Therapeutic drug monitoring | 2021

von Ward, M. | Rosella, O. | Rosella, G. | +2

6

Early Assessment With Gastrointestinal Ultrasound in Patients Hospitalised for a Flare of Ulcerative Colitis and Predicting the Need for Salvage Therapy : A Pilot Study

enthalten in: Ultrasound in medicine & biology | 2021

von Smith, R. | Taylor, K. | Friedman, A. | +3

7

Thiopurines and their optimization during infliximab induction and maintenance : A retrospective study in Crohn's disease

enthalten in: Journal of gastroenterology and hepatology | 2021

von Luber, R. | Dawson, L. | Munari, S. | +5

8

Infliximab, adalimumab and vedolizumab concentrations across pregnancy and vedolizumab concentrations in infants following intrauterine exposure

enthalten in: Alimentary pharmacology & therapeutics | 2020

von Flanagan, E. | Gibson, P. | Wright, E. | +19

9

Review article : determination of the therapeutic range for therapeutic drug monitoring of adalimumab and infliximab in patients with inflammatory bowel disease

enthalten in: Alimentary pharmacology & therapeutics | 2020

von Gibson, D. | Ward, M. | Rentsch, C. | +4

10

Higher Mucosal Healing with Tumor Necrosis Factor Inhibitors in Combination with Thiopurines Compared to Methotrexate in Crohn's Disease

enthalten in: Digestive diseases and sciences | 2019

von Vasudevan, A. | Raghunath, A. | Anthony, S. | +4